Cargando…

Lactobacillus reuteri DSM 17938 Protects against Gastric Damage Induced by Ethanol Administration in Mice: Role of TRPV1/Substance P Axis

This study aimed to evaluate the effect of Lactobacillus reuteri DSM 17938 (DSM) on ethanol-induced gastric injury, and if its possible mechanism of action is related to inhibiting the transient receptor potential vanilloid type 1 (TRPV1). We evaluated the effect of supplementing 10(8) CFU•g body wt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Ana P., Souza, Luan K. M., Araújo, Thiago S. L., de Araújo, Simone, Nogueira, Kerolayne M., Sousa, Francisca Beatriz M., Silva, Renan O., Pacífico, Dvison M., Martins, Conceição S., Brito, Gerly Anne de C., Souza, Marcellus H.L.P., Medeiros, Jand Venes R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356937/ https://www.ncbi.nlm.nih.gov/pubmed/30669695 http://dx.doi.org/10.3390/nu11010208

Ejemplares similares

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
por: Kaban, Risma K., et al.
Publicado: (2019)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
por: Urbańska, Magdalena, et al.
Publicado: (2014)

Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
por: Frerejacques, Marie, et al.
Publicado: (2020)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
por: Hernández, Armando, et al.
Publicado: (2019)

The role of Lactobacillus reuteri DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia
por: Manoppo, Jeanette, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
por: Gupta, Nitasha, et al.
Publicado: (2020)

Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice
por: West, Christine L., et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis
por: Sung, Valerie, et al.
Publicado: (2014)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum
Publicado: (2018)

Human Breast Milk Promotes the Secretion of Potentially Beneficial Metabolites by Probiotic Lactobacillus reuteri DSM 17938
por: Mai, Tu T., et al.
Publicado: (2019)

Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update
por: Patro-Gołąb, Bernadeta, et al.
Publicado: (2019)

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
por: Cui, Xuewei, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial
por: Kołodziej, Maciej, et al.
Publicado: (2017)

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial
por: Szymański, Henryk, et al.
Publicado: (2017)

Human Breast Milk Promotes the Immunomodulatory Function of Probiotic Lactobacillus reuteri DSM 17938 in the Neonatal Rat Intestine
por: Hoang, Thomas K, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
por: Savino, Francesco, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 Changes the Frequency of Foxp3(+) Regulatory T Cells in the Intestine and Mesenteric Lymph Node in Experimental Necrotizing Enterocolitis
por: Liu, Yuying, et al.
Publicado: (2013)

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial
por: Mangalat, Nisha, et al.
Publicado: (2012)

The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Man, et al.
Publicado: (2015)

Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility
por: Indrio, Flavia, et al.
Publicado: (2017)

Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938
por: Maccelli, Alessandro, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial
por: Kubota, Megumi, et al.
Publicado: (2020)

A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea
por: Sun, Xiaoqi, et al.
Publicado: (2023)

454 Pyrosequencing Analysis on Faecal Samples from a Randomized DBPC Trial of Colicky Infants Treated with Lactobacillus reuteri DSM 17938
por: Roos, Stefan, et al.
Publicado: (2013)

Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial
por: Romani Vestman, Nelly, et al.
Publicado: (2015)

Lactobacillus reuteri DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis
por: Butler, Éile, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial
por: Contreras, Andrea A. García, et al.
Publicado: (2020)

Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis
por: Hunter, Chelsea, et al.
Publicado: (2012)

Enteroadsorbent Polymethylsiloxane Polyhydrate vs. Probiotic Lactobacillus reuteri DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized Controlled Trial
por: Markovinović, Leo, et al.
Publicado: (2020)

Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients
por: Alforaidi, Sahal, et al.
Publicado: (2021)

Antibiofilm activity and NMR-based metabolomic characterization of cell-free supernatant of Limosilactobacillus reuteri DSM 17938
por: Vitale, Irene, et al.
Publicado: (2023)

Limosilactobacillus reuteri DSM 17938 reverses gut metabolic dysfunction induced by Western diet in adult rats
por: Abuqwider, Jumana, et al.
Publicado: (2023)

Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial
por: Hoy-Schulz, Yana Emmy, et al.
Publicado: (2016)

The use of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 on oral health indexes in a school population: A pilot randomized clinical trial
por: Borrell García, Carla, et al.
Publicado: (2021)

Application of ultrasound and microencapsulation on Limosilactobacillus reuteri DSM 17938 as a metabolic attenuation strategy for tomato juice probiotication
por: Giordano, Irene, et al.
Publicado: (2022)

Role of Lactobacillus reuteri DSM 17938 on Crying Time Reduction in Infantile Colic and Its Impact on Maternal Depression: A Real-Life Clinic-Based Study
por: Wadhwa, Arun, et al.
Publicado: (2022)

Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3kesen3g6qbvpvmu9grg61aapf